NewsOxford COVID-19 vaccine trial resumed after a pause from...

Oxford COVID-19 vaccine trial resumed after a pause from patient illness

-

The Oxford COVID-19 vaccine trial which was suspended following an ‘unexplained illness’ in a patient has resumed again, after getting a nod from the safety watchdogs.

On September 9th, AstraZeneca, the pharma giant co-developing the Oxford University vaccine trial announced they’ve halted the phase 2 and phase 3 clinical trial of its COVID-19 vaccine after a patient unexpectedly developed spinal cord-related complications.

Following the illness, the same vaccine under trial in the US was also halted, and the same was followed by India’s Serum Institute where the Oxford Vaccine was under the trail.

“This is a routine action which has to happen whenever there is a potentially unexplained illness in one of the trials, while it is investigated, ensuring we maintain the integrity of the trials,” AstraZeneca said in a statement.

But Saturday’s announcement said the vaccine was deemed safe to continue with the trial and AstraZeneca declined to comment on the medical condition of the patient’s condition who suffered from the rare symptom.

In India, The Serum Institute has said it will continue the trial once the Drug Controller General of India allows, Reuters reported. Brazil’s healthcare regulator ANVISA said on Saturday, it has approved the resumptions of trial after reviewing MHRA data.

AstraZeneca and Oxford vaccine is being touted as one of the world’s most advanced and promising vaccines under development, among the 100 plus others, as per WHO.

Following the unexpected pause of the trial, WHO raised concerns on the futility of people’s perpetual faith on a vaccine to curb the pandemic, while deflecting social distancing norms at the same time.

WHO’s chief scientists said this pause is a ‘wake-up call’ and it emphasized vaccine development may come with its own ups and downs. Experts, however, said such a pause is expected, if not common, and shows the development is going in the right direction.

AstraZeneca has earlier promised to deliver over 3 billion vaccine doses to governments worldwide, without profit at this time of the pandemic, which is a volume larger than any other organization so far.

On Thursday, the pharma giant’s CEO said, despite the global pause for a few days, the company can still deliver the doses by the end of this year, which is quite a big claim for a company at the time of a pandemic.

Globally, COVID-19 cases are shooting up daily, with the most cases coming from India, US followed by European nations like France. On Sunday, India’s COVID national total went up by 94k new cases to 4.7 million.

Meanwhile, globally, there are 28,791,708 confirmed cases, with 920,847 deaths around the world. The US alone has nearly 6.5 million cases.

Share this story: Oxford COVID-19 vaccine trial resumed after a pause from patient illness

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Latest news

Swiss unanimously votes for same-sex union referendum

GENEVA — In Switzerland, a controversial same-sex marriage referendum has been resoundingly approved by voters of the conservative, rich Alpine...

New Covid surge overwhelms hospitals in parts of US

WASHINGTON, D.C. — According to one of the country's top health officials, the spike in coronavirus cases in the...

China wants effeminate male celebs to man up

WASHINGTON — Macho men are in and effeminate male performers are out as Beijing expands its crackdown on China's entertainment...

Billie Eilish, BTS to perform at climate change concert

Billie Eilish, BTS, and Elton John, among others, will donate their star power to Global Citizen Live on Saturday...

Google faces off EU in court over record $5.1 billion antitrust fine

This week, Google will face the European Commission in a five-day court hearing, appealing a record $5.1 billion fine...

WHO’s Covax misses 2021 target. What went wrong?

The latest supply forecast for Covax – the programme for sharing COVID-19 vaccines around the world – suggests that accelerating vaccination...

Must read

You might also likeRELATED
Recommended to you